174 related articles for article (PubMed ID: 24695110)
1. Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
Ferraresso S; Bresolin S; Aricò A; Comazzi S; Gelain ME; Riondato F; Bargelloni L; Marconato L; Kronnie Gt; Aresu L
PLoS One; 2014; 9(4):e92707. PubMed ID: 24695110
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.
Ferraresso S; Aricò A; Sanavia T; Da Ros S; Milan M; Cascione L; Comazzi S; Martini V; Giantin M; Di Camillo B; Mazzariol S; Giannuzzi D; Marconato L; Aresu L
Sci Rep; 2017 Sep; 7(1):11591. PubMed ID: 28912427
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.
Guo H; Lin Y; Zhang H; Liu J; Zhang N; Li Y; Kong D; Tang Q; Ma D
BMC Mol Biol; 2007 Dec; 8():110. PubMed ID: 18053161
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.
Lai YH; He RY; Chou JL; Chan MW; Li YF; Tai CK
J Transl Med; 2014 Sep; 12():237. PubMed ID: 25179542
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.
Hubé F; Reverdiau P; Iochmann S; Rollin J; Cherpi-Antar C; Gruel Y
Biol Chem; 2003 Jul; 384(7):1029-34. PubMed ID: 12956419
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation-Mediated Silencing of
Zorzan E; Elgendy R; Guerra G; Da Ros S; Gelain ME; Bonsembiante F; Garaffo G; Vitale N; Piva R; Marconato L; Aresu L; Dacasto M; Giantin M
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409379
[TBL] [Abstract][Full Text] [Related]
8. Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes.
Amara K; Trimeche M; Ziadi S; Laatiri A; Hachana M; Sriha B; Mokni M; Korbi S
Int J Cancer; 2007 Dec; 121(12):2693-702. PubMed ID: 17724719
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.
Bryan JN; Jabbes M; Berent LM; Arthur GL; Taylor KH; Rissetto KC; Henry CJ; Rahmatpanah F; Rankin WV; Villamil JA; Lewis MR; Caldwell CW
BMC Genet; 2009 Nov; 10():73. PubMed ID: 19912643
[TBL] [Abstract][Full Text] [Related]
12. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma.
Schmid CA; Robinson MD; Scheifinger NA; Müller S; Cogliatti S; Tzankov A; Müller A
J Exp Med; 2015 May; 212(5):775-92. PubMed ID: 25847947
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
14. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.
Rollin J; Iochmann S; Bléchet C; Hubé F; Régina S; Guyétant S; Lemarié E; Reverdiau P; Gruel Y
Br J Cancer; 2005 Feb; 92(4):775-83. PubMed ID: 15685245
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
Ribarska T; Ingenwerth M; Goering W; Engers R; Schulz WA
Cancer Genomics Proteomics; 2010; 7(2):51-60. PubMed ID: 20335518
[TBL] [Abstract][Full Text] [Related]
17. Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach.
Da Ros S; Aresu L; Ferraresso S; Zorzan E; Gaudio E; Bertoni F; Dacasto M; Giantin M
PLoS One; 2018; 13(12):e0208709. PubMed ID: 30533020
[TBL] [Abstract][Full Text] [Related]
18. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z
BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455
[TBL] [Abstract][Full Text] [Related]
19. Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.
Zhang YW; Zhang J; Li J; Zhu JF; Yang YL; Zhou LL; Hu ZL; Zhang F
Leuk Lymphoma; 2015; 56(8):2429-38. PubMed ID: 25487076
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
